The 4 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 5.50, with a high estimate of 9.00 and a low estimate of 2.50. The median estimate represents a +280.62% increase from the last price of 1.45.
The current consensus among 4 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.18
Reporting Date Feb 27
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.